"Revolutionary" Proton Therapy Expands to More Patients


May 17, 2011

CBS3

CBS3 highlighted the continued expansion of care and research in the Roberts Proton Therapy Center, which now offers treatment to patients with cancers of the prostate, brain and spinal cord, sarcomas, recurrent cancers for which further treatment with conventional radiation would not be safe, and other types of tumors. The story highlighted an 18-year-old patient, Danielle Palaferro, who will be among the first Hodgkins lymphoma patients to be treated with proton therapy, which her family said they sought out because it will be delivered in a way that will reduce the chances of her developing breast cancer later in life. “It’s very significant in decreasing long term side effects,” said Robert Lustig, MD, director of Clinical Operations in the department of Radiation Oncology. “This allows you to spare more normal tissue. You can shape the beam and aim the beam, and not treat anything beyond where you want to treat.” Danielle will be treated by Zelig Tochner, MD, vice chairman for proton therapy in the department of Radiation Oncology. The story also noted the Radiation Oncology faculty’s role in leading last week’s meeting of the international Particle Therapy Co-Operative Group, which brought more than 500 physicians and medical physicists to Philadelphia to learn about proton therapy from Penn radiation oncologists and tour the Roberts Proton Therapy Center. Watch Video Segment